In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Fortis Healthcare has informed that ICRA has upgraded the long-term rating for Line of Credit of SRL from [ICRA] A- (ICRA A minus) to [ICRA] A (ICRA A); and the long-term rating for Line of Credit of SRL Diagnostics from [ICRA] A- (ICRA A minus) to [ICRA] A (ICRA A). The detailed letters as issued by ICRA are attached for the reference and records.
The above information is a part of company’s filings submitted to BSE.